Literature DB >> 1565204

Plasma melatonin rhythm in normal puberty: interactions of age and pubertal stages.

A Cavallo1.   

Abstract

Studies on the relation between the pineal and human puberty have yielded conflicting results, partly due to methodologic issues, such as failure to consider the characteristic secretory rhythm of melatonin, or exclusion of normal subjects. Melatonin nocturnal rhythm was assessed in 62 normal subjects (ages 5-17 years), in whom hourly blood samples were collected by constant withdrawal from 18.00 to 08.00 h. Melatonin peak and mean integrated nocturnal concentrations were highly correlated (r = 0.90, p less than 0.05) and data are shown for melatonin peak. Tanner criteria were applied for pubertal stages. Mean melatonin peak was 153.6 +/- 72.6 pg/ml for stage 1, 141.0 +/- 26.2 pg/ml for stage 2, and 116.6 +/- 43.6 pg/ml for stages 3-5. There was a significant linear trend for decreasing melatonin peak with puberty. The subjects were also grouped into discrete age groups (5-6.99 years through 15-17 years); a significant linear trend was present for decreasing melatonin peak with age. The correlation between melatonin peak and age for all cases was r = -0.29, p less than 0.05. Analysis of covariance for melatonin peak among the pubertal groups showed no relation of melatonin and puberty when age was covaried. The time of peak was not significantly different among the pubertal groups or the age groups, despite a significant linear trend for later bedtime with age. The duration of the nocturnal surge was not significantly different among the pubertal groups. The data suggest that an overlapping effect of age may mask an interaction between the pineal and normal human puberty.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1565204     DOI: 10.1159/000126147

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  12 in total

1.  Human puberty: salivary melatonin profiles in constant conditions.

Authors:  Stephanie J Crowley; Christine Acebo; Mary A Carskadon
Journal:  Dev Psychobiol       Date:  2011-09-27       Impact factor: 3.038

Review 2.  Influence of melatonin and photoperiod on animal and human reproduction.

Authors:  A Cagnacci; A Volpe
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

Review 3.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 4.  Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

Authors:  Frank M C Besag; Michael J Vasey; Kim S J Lao; Ian C K Wong
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

5.  beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.

Authors:  H De Leersnyder; M C de Blois; M Vekemans; D Sidi; E Villain; C Kindermans; A Munnich
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

Review 6.  Angelman syndrome and melatonin: What can they teach us about sleep regulation.

Authors:  Daniella Buonfiglio; Daniel L Hummer; Ariel Armstrong; John Christopher Ehlen; Jason P DeBruyne
Journal:  J Pineal Res       Date:  2020-10-11       Impact factor: 13.007

Review 7.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

8.  Hypotheses: melatonin/steroid combination contraceptives will prevent breast cancer.

Authors:  M Cohen; R A Small; A Brzezinski
Journal:  Breast Cancer Res Treat       Date:  1995-03       Impact factor: 4.872

9.  Consequences of the timing of menarche on female adolescent sleep phase preference.

Authors:  Sylvia Frey; Silvia Balu; Sarah Greusing; Nicolas Rothen; Christian Cajochen
Journal:  PLoS One       Date:  2009-04-22       Impact factor: 3.240

10.  Melatonin and Angelman Syndrome: Implications and Mathematical Model of Diurnal Secretion.

Authors:  Justyna Paprocka; Marek Kijonka; Piotr Wojcieszek; Marcin Pęcka; Ewa Emich-Widera; Maria Sokół
Journal:  Int J Endocrinol       Date:  2017-12-12       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.